{"id":"W2152976783","doi":"10.1056/nejmoa030002","title":"A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis","year":2003,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":580,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Placebo; Psoriasis Area and Severity Index; Internal medicine; Gastroenterology; Immunology; Pharmacology; Plaque psoriasis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002748909,0.0003697618,0.0005584653,0.0002363931,0.0001820848,0.000266389,0.0002922932,0.0004892789,0.002104538],"category_scores_gemma":[0.0001655844,0.00008839281,0.0002951951,0.0001551734,0.0001682024,0.0002430801,0.0001131095,0.000821295,0.0003962441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001949854,"about_ca_system_score_gemma":0.00015176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001743073,"about_ca_topic_score_gemma":0.0005111003,"domain_scores_codex":[0.9999185,0.00002268668,0.000006365193,0.00001606476,0.00001781051,0.00001875259],"domain_scores_gemma":[0.9999512,0.00001274322,0.00001365843,0.000003125269,0.00000582855,0.00001336029],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0256364,0.007355046,0.003357552,0.001642895,0.0003811452,0.001658667,0.000140833,0.0009775945,0.3191229,0.0007466085,0.004531278,0.6344491],"study_design_scores_gemma":[0.2140576,0.291387,0.06343431,0.001173156,0.004107495,0.03167451,0.0002910485,0.008708118,0.22236,0.002309558,0.1603356,0.0001617063],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9171242,0.07253277,0.004181688,0.001176181,0.0003656062,0.0004130517,0.0001469627,0.0002031045,0.003856548],"genre_scores_gemma":[0.975821,0.01770624,0.003658978,0.0006921179,0.0003138497,0.0002018156,0.0002029209,0.00001195743,0.001391194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002104538,"threshold_uncertainty_score":0.007040441,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0206780530635987,"score_gpt":0.2453775974936594,"score_spread":0.2246995444300607,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}